Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Navidea Biopharmaceuticals in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.00.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Navidea Biopharmaceuticals. This rating has held steady since July 2021, when it changed from a Buy consensus rating.